Predominance of interferon-related responses in the brain during murine malaria, as identified by microarray analysis.

PubWeight™: 0.88‹?›

🔗 View Article (PMC 2346669)

Published in Infect Immun on February 25, 2008

Authors

Jenny Miu1, Nicholas H Hunt, Helen J Ball

Author Affiliations

1: Molecular Immunopathology Unit, Bosch Institute, Medical Foundation Building (K25), University of Sydney, Sydney, New South Wales 2006, Australia.

Articles citing this

IFN-γ-producing CD4+ T cells promote experimental cerebral malaria by modulating CD8+ T cell accumulation within the brain. J Immunol (2012) 1.34

Beta interferon suppresses the development of experimental cerebral malaria. Infect Immun (2011) 0.91

The quality of methods reporting in parasitology experiments. PLoS One (2014) 0.88

Pathogenic CD8+ T cells in experimental cerebral malaria. Semin Immunopathol (2015) 0.87

Host biomarkers and biological pathways that are associated with the expression of experimental cerebral malaria in mice. Infect Immun (2008) 0.87

Eimeria falciformis infection of the mouse caecum identifies opposing roles of IFNγ-regulated host pathways for the parasite development. Mucosal Immunol (2013) 0.81

Cerebral malaria: gamma-interferon redux. Front Cell Infect Microbiol (2014) 0.81

Plasma circulating nucleic acids levels increase according to the morbidity of Plasmodium vivax malaria. PLoS One (2011) 0.80

Blast traumatic brain injury-induced cognitive deficits are attenuated by preinjury or postinjury treatment with the glucagon-like peptide-1 receptor agonist, exendin-4. Alzheimers Dement (2015) 0.78

Interferons and interferon regulatory factors in malaria. Mediators Inflamm (2014) 0.77

Splenic differentiation and emergence of CCR5(+)CXCL9(+)CXCL10(+) monocyte-derived dendritic cells in the brain during cerebral malaria. Nat Commun (2016) 0.75

IRGM3 contributes to immunopathology and is required for differentiation of antigen-specific effector CD8+ T cells in experimental cerebral malaria. Infect Immun (2015) 0.75

Articles cited by this

Bioconductor: open software development for computational biology and bioinformatics. Genome Biol (2004) 143.19

DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol (2003) 84.79

Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster. Trans R Soc Trop Med Hyg (2000) 22.12

Normalization of cDNA microarray data. Methods (2003) 18.69

Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc Natl Acad Sci U S A (1998) 13.39

Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol (2003) 12.34

Expression profiling using cDNA microarrays. Nat Genet (1999) 11.58

Functional classification of interferon-stimulated genes identified using microarrays. J Leukoc Biol (2001) 6.19

Cytokines: accelerators and brakes in the pathogenesis of cerebral malaria. Trends Immunol (2003) 3.18

Monoclonal antibody against interferon gamma can prevent experimental cerebral malaria and its associated overproduction of tumor necrosis factor. Proc Natl Acad Sci U S A (1989) 3.03

Neuronal loss and brain atrophy in mice lacking cathepsins B and L. Proc Natl Acad Sci U S A (2002) 2.54

p47 GTPases: regulators of immunity to intracellular pathogens. Nat Rev Immunol (2004) 2.52

Immunoregulatory properties of ISG15, an interferon-induced cytokine. Proc Natl Acad Sci U S A (1996) 2.45

The calpain family and human disease. Trends Mol Med (2001) 2.38

IFN-inducible GTPases and immunity to intracellular pathogens. Trends Immunol (2004) 2.11

Immunopathogenesis of cerebral malaria. Int J Parasitol (2006) 2.08

Participation of lymphocyte subpopulations in the pathogenesis of experimental murine cerebral malaria. J Immunol (1996) 2.07

In vitro and in vivo secretion of human ISG15, an IFN-induced immunomodulatory cytokine. J Immunol (1996) 1.98

Multistage regulation of Th1-type immune responses by the transcription factor IRF-1. Immunity (1997) 1.89

Locally up-regulated lymphotoxin alpha, not systemic tumor necrosis factor alpha, is the principle mediator of murine cerebral malaria. J Exp Med (2002) 1.86

Pathology of fatal and resolving Plasmodium berghei cerebral malaria in mice. Parasitology (1992) 1.78

Interferon regulatory factor-1 is required for a T helper 1 immune response in vivo. Immunity (1997) 1.70

Involvement of IFN-gamma receptor-medicated signaling in pathology and anti-malarial immunity induced by Plasmodium berghei infection. Eur J Immunol (2000) 1.68

Genomewide analysis of the host response to malaria in Kenyan children. J Infect Dis (2005) 1.66

Breakdown of the blood-brain barrier in murine cerebral malaria. Parasitology (1988) 1.47

A human 15-kDa IFN-induced protein induces the secretion of IFN-gamma. J Immunol (1991) 1.47

Pathogenic T cells in cerebral malaria. Int J Parasitol (2006) 1.45

Depletion of CD4+ or CD8+ T-cells prevents Plasmodium berghei induced cerebral malaria in end-stage disease. Parasitology (1997) 1.45

Plasmodium falciparum--infected erythrocyte adhesion induces caspase activation and apoptosis in human endothelial cells. J Infect Dis (2003) 1.44

Chemokine gene expression during fatal murine cerebral malaria and protection due to CXCR3 deficiency. J Immunol (2008) 1.42

Dendritic cells, pro-inflammatory responses, and antigen presentation in a rodent malaria infection. Immunol Rev (2004) 1.36

Perforin mediated apoptosis of cerebral microvascular endothelial cells during experimental cerebral malaria. Int J Parasitol (2006) 1.35

Common and divergent immune response signaling pathways discovered in peripheral blood mononuclear cell gene expression patterns in presymptomatic and clinically apparent malaria. Infect Immun (2006) 1.33

Early activation of microglia in the pathogenesis of fatal murine cerebral malaria. Glia (1997) 1.32

Neuronal apoptosis, metallothionein expression and proinflammatory responses during cerebral malaria in mice. Exp Neurol (2006) 1.32

Early cytokine production is associated with protection from murine cerebral malaria. Infect Immun (2005) 1.32

Apoptosis in experimental cerebral malaria: spatial profile of cleaved caspase-3 and ultrastructural alterations in different disease stages. Neuropathol Appl Neurobiol (2007) 1.28

Retracted Interferon-gamma is essential for the development of cerebral malaria. Eur J Immunol (1997) 1.23

IFN-induced 15-kDa protein is released from human lymphocytes and monocytes. J Immunol (1991) 1.22

Simultaneous host and parasite expression profiling identifies tissue-specific transcriptional programs associated with susceptibility or resistance to experimental cerebral malaria. BMC Genomics (2006) 1.20

Expression microarray analysis implicates apoptosis and interferon-responsive mechanisms in susceptibility to experimental cerebral malaria. Am J Pathol (2007) 1.20

Contribution of extracellular proteolysis and microglia to intracerebral hemorrhage. Neurocrit Care (2005) 1.18

A new strategy to amplify degraded RNA from small tissue samples for microarray studies. Nucleic Acids Res (2003) 1.18

Correlation between enhanced vascular permeability, up-regulation of cellular adhesion molecules and monocyte adhesion to the endothelium in the retina during the development of fatal murine cerebral malaria. Am J Pathol (1996) 1.17

Gene-expression profiling discriminates between cerebral malaria (CM)-susceptible mice and CM-resistant mice. J Infect Dis (2005) 1.15

Transcriptional profiling reveals suppressed erythropoiesis, up-regulated glycolysis, and interferon-associated responses in murine malaria. J Infect Dis (2004) 1.14

Redistribution and degeneration of retinal astrocytes in experimental murine cerebral malaria: relationship to disruption of the blood-retinal barrier. Glia (1996) 1.14

Tumor necrosis factor-alpha expression in the brain during fatal murine cerebral malaria: evidence for production by microglia and astrocytes. Am J Pathol (1997) 1.14

Priming of CD4+ T cells and development of CD4+ T cell memory; lessons for malaria. Parasite Immunol (2006) 1.09

Brain gene expression, metabolism, and bioenergetics: interrelationships in murine models of cerebral and noncerebral malaria. FASEB J (2004) 1.06

Brain macrophage activation in murine cerebral malaria precedes accumulation of leukocytes and CD8+ T cell proliferation. J Neuroimmunol (2005) 1.06

Genome-wide expression profiling in malaria infection reveals transcriptional changes associated with lethal and nonlethal outcomes. Infect Immun (2005) 1.04

Cellular stress and injury responses in the brains of adult Vietnamese patients with fatal Plasmodium falciparum malaria. Neuropathol Appl Neurobiol (2001) 1.03

Murine cathepsin F deficiency causes neuronal lipofuscinosis and late-onset neurological disease. Mol Cell Biol (2006) 1.02

Transcriptome profiles of host gene expression in a monkey model of human malaria. J Infect Dis (2004) 0.98

Increased expression of indoleamine 2,3-dioxygenase in murine malaria infection is predominantly localised to the vascular endothelium. Int J Parasitol (2004) 0.98

Cyclooxygenase-2 in the pathogenesis of murine cerebral malaria. J Infect Dis (2004) 0.95

Expression of major histocompatibility complex antigens on mouse brain microvascular endothelial cells in relation to susceptibility to cerebral malaria. Immunology (1997) 0.93

A role for Fas-Fas ligand interactions during the late-stage neuropathological processes of experimental cerebral malaria. J Neuroimmunol (2006) 0.91

Activation of calpains, calpastatin and spectrin cleavage in the brain during the pathology of fatal murine cerebral malaria. Neurochem Int (2005) 0.91

Widespread expression of MRP8 and MRP14 in human cerebral malaria by microglial cells. Acta Neuropathol (1998) 0.91

Expression, purification, and inhibitory activities of mouse cytotoxic T-lymphocyte antigen-2alpha. Protein Expr Purif (2003) 0.88

Reactive changes of retinal microglia during fatal murine cerebral malaria: effects of dexamethasone and experimental permeabilization of the blood-brain barrier. Am J Pathol (2000) 0.86

Cerebral calpain in fatal falciparum malaria. Neuropathol Appl Neurobiol (2007) 0.84

Fas has a role in cerebral malaria, but not in proliferation or exclusion of the murine parasite in mice. Immunogenetics (2005) 0.82

Technological platforms for microarray gene expression profiling. Adv Exp Med Biol (2007) 0.81

Brain metabolic markers reflect susceptibility status in cytokine gene knockout mice with murine cerebral malaria. Int J Parasitol (2006) 0.80

Mitochondrial anomalies are associated with the induction of intrinsic cell death proteins-Bcl(2), Bax, cytochrome-c and p53 in mice brain during experimental fatal murine cerebral malaria. Neurosci Lett (2002) 0.78

Articles by these authors

Characterization of an indoleamine 2,3-dioxygenase-like protein found in humans and mice. Gene (2007) 2.24

Kynurenine is an endothelium-derived relaxing factor produced during inflammation. Nat Med (2010) 2.12

Immunopathogenesis of cerebral malaria. Int J Parasitol (2006) 2.08

Current perspectives on the mechanism of action of artemisinins. Int J Parasitol (2006) 1.80

Indoleamine 2,3-dioxygenase-2; a new enzyme in the kynurenine pathway. Int J Biochem Cell Biol (2008) 1.64

Increased gut permeability and microbiota change associate with mesenteric fat inflammation and metabolic dysfunction in diet-induced obese mice. PLoS One (2012) 1.59

Chemokine gene expression during fatal murine cerebral malaria and protection due to CXCR3 deficiency. J Immunol (2008) 1.42

Perforin mediated apoptosis of cerebral microvascular endothelial cells during experimental cerebral malaria. Int J Parasitol (2006) 1.35

Early cytokine production is associated with protection from murine cerebral malaria. Infect Immun (2005) 1.32

The role of granulocyte macrophage-colony-stimulating factor in acute intestinal inflammation. Cell Res (2008) 1.26

Murine cerebral malaria: the whole story. Trends Parasitol (2010) 1.24

Dual ERK and phosphatidylinositol 3-kinase pathways control airway smooth muscle proliferation: differences in asthma. J Cell Physiol (2008) 1.18

Chemical alterations to murine brain tissue induced by formalin fixation: implications for biospectroscopic imaging and mapping studies of disease pathogenesis. Analyst (2011) 1.17

Detection and characterization of OX40 ligand expression in human airway smooth muscle cells: a possible role in asthma? J Allergy Clin Immunol (2004) 1.16

Cerebral malaria -- a neurovascular pathology with many riddles still to be solved. Curr Neurovasc Res (2004) 1.14

Cytochrome b5, not superoxide anion radical, is a major reductant of indoleamine 2,3-dioxygenase in human cells. J Biol Chem (2008) 1.08

CD40 and OX40 ligand are increased on stimulated asthmatic airway smooth muscle. J Allergy Clin Immunol (2005) 1.08

Brain gene expression, metabolism, and bioenergetics: interrelationships in murine models of cerebral and noncerebral malaria. FASEB J (2004) 1.06

Coincident parasite and CD8 T cell sequestration is required for development of experimental cerebral malaria. Int J Parasitol (2010) 1.03

The clinical significance of cerebrospinal fluid levels of kynurenine pathway metabolites and lactate in severe malaria. J Infect Dis (2002) 1.03

Technical advance: autofluorescence as a tool for myeloid cell analysis. J Leukoc Biol (2010) 1.02

The microcirculation in severe malaria. Microcirculation (2004) 1.02

Microvesiculation and cell interactions at the brain-endothelial interface in cerebral malaria pathogenesis. Prog Neurobiol (2010) 1.02

Metabolites of the kynurenine pathway of tryptophan metabolism in the cerebrospinal fluid of Malawian children with malaria. J Infect Dis (2003) 1.01

Heme moves to center stage in cerebral malaria. Nat Med (2007) 1.01

Increased expression of indoleamine 2,3-dioxygenase in murine malaria infection is predominantly localised to the vascular endothelium. Int J Parasitol (2004) 0.98

Indoleamine 2,3-dioxygenase 2 (IDO2) and the kynurenine pathway: characteristics and potential roles in health and disease. Amino Acids (2013) 0.98

Prostaglandin E(2) inhibits calcium current in two sub-populations of acutely isolated mouse trigeminal sensory neurons. J Physiol (2002) 0.96

Probucol promotes functional reendothelialization in balloon-injured rabbit aortas. Circulation (2003) 0.96

Placental hypoxia during placental malaria. J Infect Dis (2008) 0.96

Interferon-gamma synergises with tumour necrosis factor and lymphotoxin-alpha to enhance the mRNA and protein expression of adhesion molecules in mouse brain endothelial cells. Cytokine (2007) 0.96

Isolating vessels from the mouse brain for gene expression analysis using laser capture microdissection. Brain Res Brain Res Protoc (2002) 0.96

Gp91(phox) contributes to the development of experimental inflammatory bowel disease. Immunol Cell Biol (2011) 0.95

Cyclooxygenase-2 in the pathogenesis of murine cerebral malaria. J Infect Dis (2004) 0.95

1-L-methyltryptophan is a more effective inhibitor of vertebrate IDO2 enzymes than 1-D-methyltryptophan. Comp Biochem Physiol B Biochem Mol Biol (2010) 0.93

Inflammasome-dependent IFN-γ drives pathogenesis in Streptococcus pneumoniae meningitis. J Immunol (2012) 0.93

Synthesis of artemiside and its effects in combination with conventional drugs against severe murine malaria. Antimicrob Agents Chemother (2011) 0.92

The correlation between proinflammatory cytokines, MAdCAM-1 and cellular infiltration in the inflamed colon from TNF-alpha gene knockout mice. Immunol Cell Biol (2007) 0.91

Differential microRNA expression in experimental cerebral and noncerebral malaria. Infect Immun (2011) 0.91

A role for Fas-Fas ligand interactions during the late-stage neuropathological processes of experimental cerebral malaria. J Neuroimmunol (2006) 0.91

Role of the gut in visceral fat inflammation and metabolic disorders. Obesity (Silver Spring) (2011) 0.91

Human indoleamine 2,3-dioxygenase-2 has substrate specificity and inhibition characteristics distinct from those of indoleamine 2,3-dioxygenase-1. Amino Acids (2014) 0.90

Quantitation of brain edema and localisation of aquaporin 4 expression in relation to susceptibility to experimental cerebral malaria. Int J Clin Exp Pathol (2011) 0.90

Reduced activity of the epithelial sodium channel in malaria-induced pulmonary oedema in mice. Int J Parasitol (2010) 0.89

Both functional LTbeta receptor and TNF receptor 2 are required for the development of experimental cerebral malaria. PLoS One (2008) 0.88

Differential effects of the antioxidant alpha-lipoic acid on the proliferation of mitogen-stimulated peripheral blood lymphocytes and leukaemic T cells. Mol Immunol (2002) 0.86

The role of nicotinamide adenine dinucleotide phosphate oxidase-derived reactive oxygen species in the acquisition of metastatic ability of tumor cells. Am J Pathol (2006) 0.85

The effect of restraint stress on experimental colitis is IFN-gamma independent. J Neuroimmunol (2008) 0.84

Characterization and evolution of vertebrate indoleamine 2, 3-dioxygenases IDOs from monotremes and marsupials. Comp Biochem Physiol B Biochem Mol Biol (2009) 0.83

The crossroads of neuroinflammation in infectious diseases: endothelial cells and astrocytes. Trends Parasitol (2012) 0.83

Indoleamine 2,3-dioxygenases with very low catalytic activity are well conserved across kingdoms: IDOs of Basidiomycota. Fungal Genet Biol (2013) 0.83

The kynurenine pathway of tryptophan degradation is activated during osteoblastogenesis. Stem Cells (2015) 0.82

Molecular evolution and characterization of fungal indoleamine 2,3-dioxygenases. J Mol Evol (2010) 0.81

Identification of selective inhibitors of indoleamine 2,3-dioxygenase 2. Bioorg Med Chem Lett (2012) 0.81

Mouse and human indoleamine 2,3-dioxygenase display some distinct biochemical and structural properties. Amino Acids (2008) 0.81

Total synthesis, stereochemical assignment, and antimalarial activity of gallinamide A. Chemistry (2011) 0.80

FTIR imaging of brain tissue reveals crystalline creatine deposits are an ex vivo marker of localized ischemia during murine cerebral malaria: general implications for disease neurochemistry. ACS Chem Neurosci (2012) 0.80

Brain metabolic markers reflect susceptibility status in cytokine gene knockout mice with murine cerebral malaria. Int J Parasitol (2006) 0.80

Molecular evolution of bacterial indoleamine 2,3-dioxygenase. Gene (2011) 0.79

Effects of a redox-active agent on lymphocyte activation and early gene expression patterns. Free Radic Biol Med (2004) 0.79

Effect of indoleamine dioxygenase-1 deficiency and kynurenine pathway inhibition on murine cerebral malaria. Int J Parasitol (2008) 0.79

The evolution of three types of indoleamine 2,3 dioxygenases in fungi with distinct molecular and biochemical characteristics. Gene (2012) 0.79

Total synthesis and antimalarial activity of symplostatin 4. Org Lett (2010) 0.78

Endothelial cells potentiate interferon-γ production in a novel tripartite culture model of human cerebral malaria. PLoS One (2013) 0.78

Efficient tryptophan-catabolizing activity is consistently conserved through evolution of TDO enzymes, but not IDO enzymes. J Exp Zool B Mol Dev Evol (2015) 0.78

Synthesis of gallinamide A analogues as potent falcipain inhibitors and antimalarials. J Med Chem (2014) 0.78

Characterization and evolution of vertebrate indoleamine 2, 3-dioxygenases IDOs from monotremes and marsupials. Comp Biochem Physiol B Biochem Mol Biol (2009) 0.78

Vascular expression, activity and function of indoleamine 2,3-dioxygenase-1 following cerebral ischaemia-reperfusion in mice. Naunyn Schmiedebergs Arch Pharmacol (2011) 0.78

A metabolomic approach to ionotropic glutamate receptor subtype function: a nuclear magnetic resonance in vitro investigation. J Cereb Blood Flow Metab (2005) 0.76

Probing for antiparasitic drugs. Mini Rev Med Chem (2006) 0.75

Improved spectrophotometric human interferon-gamma bioassay. J Immunol Methods (2013) 0.75